The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia.
Gaebler AJ, Finner-Prével M, Lammertz S, Schaffrath S, Eisner P, Stöhr F, Röcher E, Winkler L, Kaleta P, Lenzen L, Augustin M, Hovancakova J, Schwemmer L, Stormanns E, Keskin F, Hendricks F, Paulzen M, Gründer G, Schneider F; APIC Consortium; Mathiak K.
Gaebler AJ, et al. Among authors: winkler l.
Br J Clin Pharmacol. 2022 Jul;88(7):3193-3200. doi: 10.1111/bcp.15223. Epub 2022 Feb 14.
Br J Clin Pharmacol. 2022.
PMID: 35380747
Free article.